-
Lifespan tree of brain anatomy: diagnostic values for motor and cognitive neurodegenerative diseases
Authors:
Pierrick Coupé,
Boris Mansencal,
José V. Manjón,
Patrice Péran,
Wassilios G. Meissner,
Thomas Tourdias,
Vincent Planche
Abstract:
The differential diagnosis of neurodegenerative diseases, characterized by overlapping symptoms, may be challenging. Brain imaging coupled with artificial intelligence has been previously proposed for diagnostic support, but most of these methods have been trained to discriminate only isolated diseases from controls. Here, we develop a novel machine learning framework, named lifespan tree of brain…
▽ More
The differential diagnosis of neurodegenerative diseases, characterized by overlapping symptoms, may be challenging. Brain imaging coupled with artificial intelligence has been previously proposed for diagnostic support, but most of these methods have been trained to discriminate only isolated diseases from controls. Here, we develop a novel machine learning framework, named lifespan tree of brain anatomy, dedicated to the differential diagnosis between multiple diseases simultaneously. It integrates the modeling of volume changes for 124 brain structures during the lifespan with non-linear dimensionality reduction and synthetic sampling techniques to create easily interpretable representations of brain anatomy over the course of disease progression. As clinically relevant proof-of-concept applications, we constructed a cognitive lifespan tree of brain anatomy for the differential diagnosis of six causes of neurodegenerative dementia and a motor lifespan tree of brain anatomy for the differential diagnosis of four causes of parkinsonism using 37594 MRI as a training dataset. This original approach enhanced significantly the efficiency of differential diagnosis in the external validation cohort of 1754 cases, outperforming existing state-of-the art machine learning techniques. Lifespan tree holds promise as a valuable tool for differential diagnostic in relevant clinical conditions, especially for diseases still lacking effective biological markers.
△ Less
Submitted 13 February, 2025;
originally announced February 2025.
-
Structuring, Sequencing, Staging, Selecting: the 4S method for the longitudinal analysis of multidimensional measurement scales in chronic diseases
Authors:
Tiphaine Saulnier,
Wassilios G. Meissner,
Margherita Fabbri,
Alexandra Foubert-Samier,
Cécile Proust-Lima
Abstract:
In clinical studies, measurement scales are often collected to report disease-related manifestations from clinician or patient perspectives. Their analysis can help identify relevant manifestations throughout the disease course, enhancing knowledge of disease progression and guiding clinicians in providing appropriate support. However, the analysis of measurement scales in health studies is not st…
▽ More
In clinical studies, measurement scales are often collected to report disease-related manifestations from clinician or patient perspectives. Their analysis can help identify relevant manifestations throughout the disease course, enhancing knowledge of disease progression and guiding clinicians in providing appropriate support. However, the analysis of measurement scales in health studies is not straightforward as made of repeated, ordinal, and potentially multidimensional item data. Their sum-score summaries may considerably reduce information and impend interpretation, their change over time occurs along clinical progression, and as many other longitudinal processes, their observation may be truncated by events. This work establishes a comprehensive strategy in four consecutive steps to leverage repeated data from multidimensional measurement scales. The 4S method successively (1) identifies the scale structure into subdimensions satisfying three calibration assumptions (unidimensionality, conditional independence, increasing monotonicity), (2) describes each subdimension progression using a joint latent process model which includes a continuous-time item response theory model for the longitudinal subpart, (3) aligns each subdimension's progression with disease stages through a projection approach, and (4) identifies the most informative items across disease stages using the Fisher's information. The method is comprehensively illustrated in multiple system atrophy (MSA), an alpha-synucleinopathy, with the analysis of daily activity and motor impairments over disease progression. The 4S method provides an effective and complete analytical strategy for any measurement scale repeatedly collected in health studies.
△ Less
Submitted 11 July, 2024;
originally announced July 2024.
-
Patient-perceived progression in multiple system atrophy: natural history of quality of life
Authors:
Tiphaine Saulnier,
Margherita Fabbri,
Mélanie Le Goff,
Catherine Helmer,
Anne Pavy-Le Traon,
Wassilios G. Meissner,
Olivier Rascol,
Cécile Proust-Lima,
Alexandra Foubert-Samier
Abstract:
Health-related quality of life (Hr-QoL) scales provide crucial information on neurodegenerative disease progression, help improving patient care, and constitute a meaningful endpoint for therapeutic research. However, Hr-QoL progression is usually poorly documented, as for multiple system atrophy (MSA), a rare and rapidly progressing alpha-synucleinopathy. This work aimed to describe Hr-QoL progre…
▽ More
Health-related quality of life (Hr-QoL) scales provide crucial information on neurodegenerative disease progression, help improving patient care, and constitute a meaningful endpoint for therapeutic research. However, Hr-QoL progression is usually poorly documented, as for multiple system atrophy (MSA), a rare and rapidly progressing alpha-synucleinopathy. This work aimed to describe Hr-QoL progression during the natural course of MSA, explore disparities between patients, and identify informative items using a four-step statistical strategy.We leveraged the data of the French MSA cohort comprising annual assessments with the MSA-QoL questionnaire for more than 500 patients over up to 11 years. The four-step strategy (1) determined the subdimensions of Hr-QoL in MSA; (2) modelled the subdimension trajectories over time, accounting for the risk of death; (3) mapped the sequence of item impairments with disease stages; and (4) identified the most informative items specific to each disease stage.Among the 536 patients included, 50% were women and they were aged on average 65.1 years old at entry. Among them, 63.1% died during the follow-up. Four dimensions were identified. In addition to the original motor, nonmotor, and emotional domains, an oropharyngeal component was highlighted. While the motor and oropharyngeal domains deteriorated rapidly, the nonmotor and emotional aspects were already slightly to moderately impaired at cohort entry and deteriorated slowly over the course of the disease. Impairments were associated with sex, diagnosis subtype, and delay since symptom onset. Except for the emotional domain, each dimension was driven by key identified items.Hr-QoL is a multidimensional concept that deteriorates progressively over the course of MSA and brings essential knowledge for improving patient care. As exemplified with MSA, the thorough description of Hr-QoL using the 4-step original analysis can provide new perspectives on neurodegenerative diseases' management to ultimately deliver better support focused on the patient's perspective.
△ Less
Submitted 22 September, 2023;
originally announced September 2023.
-
Describing complex disease progression using joint latent class models for multivariate longitudinal markers and clinical endpoints
Authors:
Cécile Proust-Lima,
Tiphaine Saulnier,
Viviane Philipps,
Anne Pavy-Le Traon,
Patrice Péran,
Olivier Rascol,
Wassilios G Meissner,
Alexandra Foubert-Samier
Abstract:
Neurodegenerative diseases are characterized by numerous markers of progression and clinical endpoints. For instance, Multiple System Atrophy (MSA), a rare neurodegenerative synucleinopathy, is characterized by various combinations of progressive autonomic failure and motor dysfunction, and a very poor prognosis. Describing the progression of such complex and multi-dimensional diseases is particul…
▽ More
Neurodegenerative diseases are characterized by numerous markers of progression and clinical endpoints. For instance, Multiple System Atrophy (MSA), a rare neurodegenerative synucleinopathy, is characterized by various combinations of progressive autonomic failure and motor dysfunction, and a very poor prognosis. Describing the progression of such complex and multi-dimensional diseases is particularly difficult. One has to simultaneously account for the assessment of multivariate markers over time, the occurrence of clinical endpoints, and a highly suspected heterogeneity between patients. Yet, such description is crucial for understanding the natural history of the disease, staging patients diagnosed with the disease, unravelling subphenotypes, and predicting the prognosis. Through the example of MSA progression, we show how a latent class approach modeling multiple repeated markers and clinical endpoints can help describe complex disease progression and identify subphenotypes for exploring new pathological hypotheses. The proposed joint latent class model includes class-specific multivariate mixed models to handle multivariate repeated biomarkers possibly summarized into latent dimensions and class-and-cause-specific proportional hazard models to handle time-to-event data. Maximum likelihood estimation procedure, validated through simulations is available in the lcmm R package. In the French MSA cohort comprising data of 598 patients during up to 13 years, five subphenotypes of MSA were identified that differ by the sequence and shape of biomarkers degradation, and the associated risk of death. In posterior analyses, the five subphenotypes were used to explore the association between clinical progression and external imaging and fluid biomarkers, while properly accounting for the uncertainty in the subphenotypes membership.
△ Less
Submitted 31 January, 2023; v1 submitted 10 February, 2022;
originally announced February 2022.
-
Joint models for the longitudinal analysis of measurement scales in the presence of informative dropout
Authors:
Tiphaine Saulnier,
Viviane Philipps,
Wassilios G Meissner,
Olivier Rascol,
Anne Pavy-Le Traon,
Alexandra Foubert-Samier,
Cécile Proust-Lima
Abstract:
In health cohort studies, repeated measures of markers are often used to describe the natural history of a disease. Joint models allow to study their evolution by taking into account the possible informative dropout usually due to clinical events. However, joint modeling developments mostly focused on continuous Gaussian markers while, in an increasing number of studies, the actual quantity of int…
▽ More
In health cohort studies, repeated measures of markers are often used to describe the natural history of a disease. Joint models allow to study their evolution by taking into account the possible informative dropout usually due to clinical events. However, joint modeling developments mostly focused on continuous Gaussian markers while, in an increasing number of studies, the actual quantity of interest is non-directly measurable; it constitutes a latent variable evaluated by a set of observed indicators from questionnaires or measurement scales. Classical examples include anxiety, fatigue, cognition. In this work,we explain how joint models can be extended to the framework of a latent quantity measured over time by indicators of different nature (e.g. continuous, binary, ordinal). The longitudinal submodel describes the evolution over time of the quantity of interest defined as a latent process in a structural mixed model, and links the latent process to each observation of the indicators through appropriate measurement models. Simultaneously, the risk of multi-cause event is modelled via a proportional cause-specific hazard model that includes a function of the mixed model elements as linear predictor to take into account the association between the latent process and the risk of event. Estimation, carried out in the maximum likelihood framework and implemented in the R-package JLPM, has been validated by simulations. The methodology is illustrated in the French cohort on Multiple-System Atrophy (MSA), a rare and fatal neurodegenerative disease, with the study of dysphagia progression over time stopped by the occurrence of death.
△ Less
Submitted 31 March, 2022; v1 submitted 6 October, 2021;
originally announced October 2021.
